Executive Summary The Food and Drug Administration (“FDA”) released five regulatory and guidance documents pertaining to compounding in an effort to provide clarity to pharmaceutical stakeholders. The documents, issued pursuant to the Drug Quality and Security Act (“Act”), describe expectations regarding compliance with current good manufacturing practices (“cGMPs”) for compounding outsourcing facilities and standards for…Read More
FDA Publishes Compounding Guidance, but Where Are the Regulations?
Posted on August 1, 2014 in Health Law News
Published by: Hall Render